Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06593613 · ClinicalTrials.gov registry record · NA
Pilot Trial of the RUBI Program for Autistic Adults
A NA study of Autism Spectrum Disorder and Parenting, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 3
- Study locations
NCT06593613: Recruiting NA study of Autism Spectrum Disorder and Parenting, sponsored by Seattle Children's Hospital.
NCT06593613 is a NA study of Autism Spectrum Disorder and Parenting that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 80 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06593613, a NA study of Autism Spectrum Disorder and Parenting, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to evaluate if a redesigned version of the RUBI parenting intervention can reduce challenging behaviors and improve adaptive skills in autistic adults with co-occurring challenging behaviors. The main questions it aims to answer are: * Is the redesigned RUBI intervention feasible and acceptable for autistic adults and their families? * Does the redesigned RUBI intervention reduce challenging behaviors and enhance the quality of life for autistic adults? * Researchers will compare the redesigned RUBI intervention to an active control group, Introduction to the Science and Lived Experience of Autism (ISLEA), to see if RUBI is more effective in improving outcomes for autistic adults and their families. Participants will: * Attend sessions where they receive either the RUBI intervention or the ISLEA program. * Engage in activities designed to promote communication, co-regulation, and autonomy in the context of supporting autistic adults. * Complete assessments at the start, throughout, and at the end of the 20-week trial to evaluate outcomes such as challenging behaviors, adaptive skills, and quality of life.
Primary Outcome
The EDI is an informant report measure of emotion dysregulation over the past 7 days, rated on a five-point scale from "not at all" to "very severe." The EDI produces scores for Reactivity and Dysphoria. Cronbach's alpha ranges from .90-.97.
Conditions Studied
Interventions
- BEHAVIORAL RUBI-A
- BEHAVIORAL R-ISLEA
Study Locations (3)
Florida
- Els for Autism Foundation - Jupiter
Pennsylvania
- A.J. Drexel Autism Institute - Philadelphia
Washington
- Seattle Children's Autism Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What NCT06593613 shows while recruiting
NCT06593613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower).
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which RUBI-A is the first listed.
NCT06593613 reports a single indexed study location in Florida, Pennsylvania, Washington.
Frequently Asked Questions
What is clinical trial NCT06593613 about?
NCT06593613 is a clinical study titled "Pilot Trial of the RUBI Program for Autistic Adults". The goal of this clinical trial is to evaluate if a redesigned version of the RUBI parenting intervention can reduce challenging behaviors and improve adaptive skills in autistic adults with co-occurring challenging behaviors. The main questions it aims to answer are: * Is the redesigned RUBI inter...
What is the current status of trial NCT06593613?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-09-01. Estimated completion is 2024-12-31.
What conditions does trial NCT06593613 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Parenting, Behavior.
What interventions are being tested in trial NCT06593613?
The interventions under investigation include: RUBI-A (BEHAVIORAL), R-ISLEA (BEHAVIORAL).
Who is sponsoring clinical trial NCT06593613?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06593613 being conducted?
This trial has 3 study locations across Florida, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06593613's enrollment target sits among peer trials
80 89th of 224 higher than 126 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI